Picture of Align Technology logo

ALGN Align Technology Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m-1.26%
3m+7.86%
6m+1.09%
1yr-25.48%
Volume Change (%)
10d/3m-27.83%
Price vs... (%)
52w High-23.77%
50d MA+1.74%
200d MA+7.07%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)32.73
PEG Ratio (f)1.15
EPS Growth (f)39.79%
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value6.53
Price to Tang. Book7.58
Price to Free Cashflow38.98
Price to Sales6.14
EV to EBITDA28.93

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital16.01%
Return on Equity12.31%
Operating Margin16.66%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue$m2,406.82,471.943,952.583,734.643,862.264,042.434,469.9514.45%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%+7.49+324.8-58.71-49.34+26.27+56.31+13.27n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Align Technology EPS forecast chart

Profile Summary

Align Technology, Inc. is a global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad computer-aided design and computer-aided manufacturing (CAD/CAM) software for digital orthodontics and restorative dentistry. The Company provides Align Digital Platform. Its segments include Clear Aligner, and Imaging Systems and CAD/CAM Services (Systems and Services). The Clear Aligner segment consists of comprehensive products, non-comprehensive products and non-case products. Its comprehensive products include Invisalign Comprehensive and Invisalign First. The Company's non-case products include retention products, Invisalign training and adjusting tools. It offers up to four sets of custom clear aligners called Vivera retainers. The Systems and Services segment consists of its iTero intraoral scanning systems. Its services include subscription software, disposables, rentals, leases and pay per scan services.

Directors

Last Annual
December 31st, 2023
Last Interim
December 31st, 2023
Incorporated
April 3rd, 1997
Public Since
January 26th, 2001
No. of Shareholders
52
No. of Employees
21,610
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconNASDAQ Global Select Market
Shares in Issue
75,252,462

ALGN Share Price Performance

Upcoming Events for ALGN

Q1 2024 Align Technology Inc Earnings Release

Q1 2024 Align Technology Inc Earnings Call

Align Technology Inc Annual Shareholders Meeting

Align Technology Inc Annual Shareholders Meeting

Q2 2024 Align Technology Inc Earnings Release

Similar to ALGN

Picture of 10X Genomics logo

10X Genomics

us flag iconNASDAQ Global Select Market

Picture of Accuray logo

Accuray

us flag iconNASDAQ Global Select Market

Picture of Akoya Biosciences logo

Akoya Biosciences

us flag iconNASDAQ Global Select Market

Picture of Alphatec Holdings logo

Alphatec Holdings

us flag iconNASDAQ Global Select Market

Picture of Angiodynamics logo

Angiodynamics

us flag iconNASDAQ Global Select Market

FAQ